News

Filter

Current filters:

Ropinirole Hcl

1 to 9 of 80 results

Azilect helps "double 2nd-line MAO-Bs in PD"

16-03-2009

Decision Resources says that second-line Parkinson's disease patient's share of monoamine oxidase-B inhibitors…

AzilectBoehringer IngelheimCarbidopaDopamineDopamine HydrochlorideDoparGlaxoSmithKlineGSKLevodopaLodosynMirapexPramipexoleRasagilineRequipRopinirole Hcl

Stock Commentary - Europe - week to June 23, 2008

30-06-2008

EUROPEAN: bourses, following a positive start, were all down significantly lower for the reporting week…

AspirinAstraZenecaBayerBayerGlaxoSmithKlineGSKMerck KGaARequipRequip XLRopinirole Extended Release TabletsRopinirole HclShireWyeth

Stock Commentary - Europe - week to June 16, 2008

23-06-2008

EUROPEAN: bourses were all down during the reported week to June 16, despite some upbeat performances…

AspirinAventis PharmaBayerBayerGlaxoSmithKlineGSKNovartisparoxetinePaxilRequipRequip XLRocheRopinirole Extended Release TabletsRopinirole HclSanofi-Aventis

FDA approval for GSK

23-06-2008

UK-based drug major GlaxoSmithKline's Requip XL (ropinirole extended-release tablets), an oral once-daily…

DopamineDopamine HydrochlorideDoparGlaxoSmithKlineGSKLevodopaNystatinOralRequipRequip XLRopinirole Extended Release TabletsRopinirole Hcl

GSK launches once-daily ReQuip XL in UK

19-05-2008

GlaxoSmithKline launched a new treatment for Parkinson's disease in the UK on May 15. ReQuip XL (ropinirole)…

DopamineDopamine HydrochlorideGlaxoSmithKlineGSKNystatinOralRequipRequip XLRopinirole Extended Release TabletsRopinirole Hcl

1 to 9 of 80 results

COMPANY SPOTLIGHT

Menarini

Back to top